Atara Biotherapeutics (ATRA) Assets (QoQ) (2014 - 2026)
Atara Biotherapeutics (ATRA) Assets (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Atara Biotherapeutics | 144.47 Mn | 127.92 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.14% |
| Mar 31, 2026 | -1.18% |
| Dec 31, 2025 | -32.92% |
| Sep 30, 2025 | -18.25% |
| Jun 30, 2025 | -40.52% |
| Mar 31, 2025 | -43.14% |
| Dec 31, 2024 | -23.55% |
| Sep 30, 2024 | 21.68% |
| Jun 30, 2024 | -29.04% |
| Mar 31, 2024 | -0.14% |
| Dec 31, 2023 | -12.33% |
| Sep 30, 2023 | -23.39% |
| Jun 30, 2023 | -18.42% |
| Mar 31, 2023 | -19.75% |
| Dec 31, 2022 | 2.20% |
| Sep 30, 2022 | -15.55% |
| Jun 30, 2022 | 9.78% |
| Mar 31, 2022 | -15.13% |
| Dec 31, 2021 | 4.05% |
| Sep 30, 2021 | -1.50% |